At the news
? NEUTRALIMPACT 2/10 8-K filed Jul 15, 2026 at 08:00 ET
Profound Medical announced its TULSA Procedure will be featured in multiple presentations at the Society of Robotic Surgery Annual Meeting (SRS2026) in Fort Lauderdale, July 23-26, 2026. The company was also selected as one of eight companies for the Society of Incisionless Surgery plenary session, and management will participate in an investor session moderated by Stifel and Wells Fargo analysts. No financial data or guidance was provided.
- TULSA Procedure highlighted in several presentations at SRS2026 (July 23-26, 2026)
- CAPTAIN randomized controlled trial primary safety outcomes to be presented
- Profound selected as one of only eight companies for SIS plenary session
- Management to participate in investor session moderated by Stifel and Wells Fargo analysts on July 22, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access